
USFDA APPLICATION NUMBER - 210526 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 8MG;EQ 2MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| AMPHETAMINE(UNII: CK833KGX7E) (AMPHETAMINE - UNII:CK833KGX7E) | AMPHETAMINE | 20mg | 10mg | 15mg | 2.5mg in 1 | 5mg |
Inactive Ingredients
| Ingredient Name | NextWave Pharmaceuticals, Inc |
|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | |
| CROSPOVIDONE(2S7830E561) | |
| GLYCERIN(PDC6A3C0OX) | |
| GUAR GUM(E89I1637KE) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MANNITOL(3OWL53L36A) | |
| METHYLPARABEN(A2I8C7HI9T) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)(461P5CJN6T) | |
| POLYSORBATE 80(6OZP39ZG8H) | |
| POLYVINYL ACETATE(32K497ZK2U) | |
| POVIDONE(FZ989GH94E) | |
| PROPYLPARABEN(Z8IX2SC1OH) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| SODIUM POLYSTYRENE SULFONATE(1699G8679Z) | |
| SUCRALOSE(96K6UQ3ZD4) | |
| TALC(7SEV7J4R1U) | |
| TRIACETIN(XHX3C3X673) | |
| XANTHAN GUM(TTV12P4NEE) |